Business Description
Marvel Biosciences Corp
NAICS : 541714
SIC : 3741
ISIN : CA57384M1077
Description
Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | -13.46 | |||||
| Debt-to-Equity | -0.56 | |||||
| Debt-to-EBITDA | -2.36 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 13.6 | |||||
| 3-Year FCF Growth Rate | 27 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.9 | |||||
| 9-Day RSI | 43.9 | |||||
| 14-Day RSI | 46.31 | |||||
| 3-1 Month Momentum % | -4.78 | |||||
| 6-1 Month Momentum % | 26.11 | |||||
| 12-1 Month Momentum % | 26.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.14 | |||||
| Quick Ratio | 0.14 | |||||
| Cash Ratio | 0.05 | |||||
| Days Payable | 6121.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.2 | |||||
| Shareholder Yield % | -10.45 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -318.57 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -10.91 | |||||
| EV-to-EBITDA | -10.91 | |||||
| EV-to-FCF | -6.57 | |||||
| Earnings Yield (Greenblatt) % | -9.17 | |||||
| FCF Yield % | -19.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MBCOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Marvel Biosciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.028 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 97.83 | ||
| 14-Day RSI | 46.31 | ||
| 14-Day ATR ($) | 0.009 | ||
| 20-Day SMA ($) | 0.112298 | ||
| 12-1 Month Momentum % | 26.96 | ||
| 52-Week Range ($) | 0.0365 - 0.14 | ||
| Shares Outstanding (Mil) | 44.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Marvel Biosciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Marvel Biosciences Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Marvel Biosciences Corp Frequently Asked Questions
What is Marvel Biosciences Corp(MBCOF)'s stock price today?
The current price of MBCOF is $0.10. The 52 week high of MBCOF is $0.14 and 52 week low is $0.04.
When is next earnings date of Marvel Biosciences Corp(MBCOF)?
The next earnings date of Marvel Biosciences Corp(MBCOF) is .
Does Marvel Biosciences Corp(MBCOF) pay dividends? If so, how much?
Marvel Biosciences Corp(MBCOF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers